A Successful Sexual Assault Resistance Program Also Reduced Intimate Partner Violence.

Despite several parallels between intimate partner violence (IPV) and sexual assault (SA), programs designed to reduce either of these forms of violence against women rarely evaluate the impact on both IPV and SA. Accordingly, we investigated whether one such program (the Enhanced Assess, Acknowledge, Act (EAAA) Sexual Assault Resistance program), designed to help university-aged women resist SA, could also reduce subsequent IPV. Women university students who were enrolled in the Sexual Assault Resistance Education (SARE) randomized controlled trial examining the impact of the EAAA program on SA, were recruited immediately after completing the last survey in the SARE trial.

Testing the effectiveness of a sexual assault resistance programme in 'real-world' implementation.

In a multi-site randomized controlled trial (RCT), the EAAA programme designed for first year university women (17-24 years old) was shown to reduce the likelihood of any (attempted and completed) rape in the next year by 50% (Senn, C. Y., Eliasziw, M.

Bottom-trawling signals lost in sediment: A combined biogeochemical and modeling approach to early diagenesis in a perturbed coastal area of the southern Baltic Sea.

Trawl-fishing is broadly considered to be one of the most destructive anthropogenic activities toward benthic ecosystems. In this study, we examine the effects of bottom-contact fishing by otter trawls on the geochemistry and macrofauna in sandy silt sediment in an area of the Baltic Sea where clear spatial patterns in trawling activity were previously identified by acoustic mapping. We calibrated an early diagenetic model to biogeochemical data from various coring locations.

Neurofibromatosis- and schwannomatosis-associated tumors: Approaches to genetic testing and counseling considerations.

Neurofibromatosis (NF) and schwannomatosis (SWN) are genetic conditions characterized by the risk of developing nervous system tumors. Recently revised diagnostic criteria include the addition of genetic testing to confirm a pathogenic variant, as well as to detect the presence of mosaicism. Therefore, the use and interpretation of both germline and tumor-based testing have increasing importance in the diagnostic approach, treatment decisions, and risk stratification of these conditions.

Parent perspectives on disclosing a pediatric neurofibromatosis type 1 diagnosis.

Neurofibromatosis 1 (NF1) is a common genetic disorder typically diagnosed in childhood and characterized by cutaneous findings, nerve sheath tumors, skeletal abnormalities, malignancies, and developmental differences. Due to its variability, NF1 is an unpredictable condition that parents have concerns about discussing with their children. While there are publications addressing the disclosure of genetic conditions in general, no NF1-specific disclosure literature exists.